Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

Abstract Real-world evidence (RWE), the understanding of treatment effectiveness in clinical
practice generated from longitudinal patient-level data from the routine operation of the …

Purpose This phase 3 clinical trial evaluated the efficacy and safety of viloxazine extended-
release capsules (VLX-ER) as a monotherapy for attention-deficit/hyperactivity disorder …

Background Timely recognition and appropriate treatment of attention-deficit/hyperactivity
disorder (ADHD) are essential to enhance long-term outcomes of individuals with ADHD …

Background Although often intended for long-term treatment, discontinuation of medication
for ADHD is common. However, cross-national estimates of discontinuation are missing due …

Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Introduction: This systematic review provides supporting evidence for the accompanying
clinical practice guideline on the treatment of central disorders of hypersomnolence in adults …

Importance Concerns over the mental health of young people have been increasing over the
past decade, especially with the rise in mental health burden seen during the COVID-19 …

Psychostimulant users are typically young adults. We have conducted a narrative review of
neuropsychiatric harms associated with the psychostimulants methamphetamine …

Background Clinically significant attention‐deficit/hyperactivity disorder (ADHD) symptoms
are common and impairing in children and youth with autism spectrum disorder (ASD). The …